Literature DB >> 21980002

Relationships between visual field sensitivity and spectral absorption properties of the neuroretinal rim in glaucoma by multispectral imaging.

Jonathan Denniss1, Ingo Schiessl, Vincent Nourrit, Cecilia H Fenerty, Ramesh Gautam, David B Henson.   

Abstract

PURPOSE: To investigate the relationship between neuroretinal rim (NRR) differential light absorption (DLA, a measure of spectral absorption properties) and visual field (VF) sensitivity in primary open-angle glaucoma (POAG).
METHODS: Patients diagnosed with (n = 22) or suspected of having (n = 7) POAG were imaged with a multispectral system incorporating a modified digital fundus camera, 250-W tungsten-halogen lamp, and fast-tuneable liquid crystal filter. Five images were captured sequentially within 1.0 second at wavelengths selected according to absorption properties of hemoglobin (range, 570-610 nm), and a Beer-Lambert law model was used to produce DLA maps of residual NRR from the images. Patients also underwent VF testing. Differences in NRR DLA in vertically opposing 180° and 45° sectors either side of the horizontal midline were compared with corresponding differences in VF sensitivity on both decibel and linear scales by Spearman's rank correlation.
RESULTS: The decibel VF sensitivity scale showed significant relationships between superior-inferior NRR DLA difference and sensitivity differences between corresponding VF areas in 180° NRR sectors (Spearman ρ = 0.68; P < 0.0001), superior-/inferior-temporal 45° NRR sectors (ρ = 0.57; P < 0.002), and superior-/inferior-nasal 45° NRR sectors (ρ = 0.59; P < 0.001). Using the linear VF sensitivity scale significant relationships were found for 180° NRR sectors (ρ = 0.62; P < 0.0002) and superior-inferior-nasal 45° NRR sectors (ρ = 0.53; P < 0.002). No significant difference was found between correlations using the linear or decibel VF sensitivity scales.
CONCLUSIONS: Residual NRR DLA is related to VF sensitivity in POAG. Multispectral imaging may provide clinically important information for the assessment and management of POAG.

Entities:  

Mesh:

Year:  2011        PMID: 21980002      PMCID: PMC3230313          DOI: 10.1167/iovs.11-8302

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  29 in total

1.  Spectroscopic analysis of changes in remitted illumination: the response to increased neural activity in brain.

Authors:  J Mayhew; Y Zheng; Y Hou; B Vuksanovic; J Berwick; S Askew; P Coffey
Journal:  Neuroimage       Date:  1999-09       Impact factor: 6.556

2.  Neurovascular coupling investigated with two-dimensional optical imaging spectroscopy in rat whisker barrel cortex.

Authors:  J Berwick; D Johnston; M Jones; J Martindale; P Redgrave; N McLoughlin; I Schiessl; J E W Mayhew
Journal:  Eur J Neurosci       Date:  2005-10       Impact factor: 3.386

3.  Structure-function relationships using confocal scanning laser ophthalmoscopy, optical coherence tomography, and scanning laser polarimetry.

Authors:  Christopher Bowd; Linda M Zangwill; Felipe A Medeiros; Ivan M Tavares; Esther M Hoffmann; Rupert R Bourne; Pamela A Sample; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

4.  Oxygen saturation levels in the juxta-papillary retina in eyes with glaucoma.

Authors:  Mami Ito; Koichiro Murayama; Tatsuya Deguchi; Masayuki Takasu; Tamir Gil; Makoto Araie; Gholam Peyman; Shin Yoneya
Journal:  Exp Eye Res       Date:  2008-01-03       Impact factor: 3.467

5.  Nonlinear registration for scanned retinal images: application to ocular polarimetry.

Authors:  Vincent Nourrit; Juan M Bueno; Brian Vohnsen; Pablo Artal
Journal:  Appl Opt       Date:  2008-10-10       Impact factor: 1.980

6.  A comparative study of the effects of brinzolamide and dorzolamide on retinal oxygen saturation and ocular microcirculation in patients with primary open-angle glaucoma.

Authors:  B Siesky; A Harris; L B Cantor; L Kagemann; Y Weitzman; L McCranor; C Marques; A Werne; E Stefansson
Journal:  Br J Ophthalmol       Date:  2008-04       Impact factor: 4.638

7.  Discrimination between glaucomatous and nonglaucomatous eyes using quantitative imaging devices and subjective optic nerve head assessment.

Authors:  Julio E Deleón-Ortega; Stella N Arthur; Gerald McGwin; Aiyuan Xie; Blythe E Monheit; Christopher A Girkin
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

8.  Automatic retinal oximetry.

Authors:  Sveinn Hakon Hardarson; Alon Harris; Robert Arnar Karlsson; Gisli Hreinn Halldorsson; Larry Kagemann; Ehud Rechtman; Gunnar Már Zoega; Thor Eysteinsson; Jon Atli Benediktsson; Adalbjorn Thorsteinsson; Peter Koch Jensen; James Beach; Einar Stefánsson
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-11       Impact factor: 4.799

9.  Global data on visual impairment in the year 2002.

Authors:  Serge Resnikoff; Donatella Pascolini; Daniel Etya'ale; Ivo Kocur; Ramachandra Pararajasegaram; Gopal P Pokharel; Silvio P Mariotti
Journal:  Bull World Health Organ       Date:  2004-12-14       Impact factor: 9.408

10.  Oxygen saturation in optic nerve head structures by hyperspectral image analysis.

Authors:  James Beach; Jinfeng Ning; Bahram Khoobehi
Journal:  Curr Eye Res       Date:  2007-02       Impact factor: 2.424

View more
  3 in total

1.  Retinal hyperspectral imaging in the 5xFAD mouse model of Alzheimer's disease.

Authors:  Jeremiah K H Lim; Qiao-Xin Li; Tim Ryan; Phillip Bedggood; Andrew Metha; Algis J Vingrys; Bang V Bui; Christine T O Nguyen
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

2.  Towards Patient-Tailored Perimetry: Automated Perimetry Can Be Improved by Seeding Procedures With Patient-Specific Structural Information.

Authors:  Jonathan Denniss; Allison M McKendrick; Andrew Turpin
Journal:  Transl Vis Sci Technol       Date:  2013-05-31       Impact factor: 3.283

Review 3.  The Future of Imaging in Detecting Glaucoma Progression.

Authors:  Fabio Lavinsky; Gadi Wollstein; Jenna Tauber; Joel S Schuman
Journal:  Ophthalmology       Date:  2017-12       Impact factor: 14.277

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.